Skip to content
01/26
  • McLaren -Honda F1 Team to boost performance through technologies
  • Stock in Action: Google (NASDAQ GOOG) Enters the Wireless Market
  • Welcome to the Summer of Bitcoin
  • Stock Alert: JetBlue Airways Corporation (NASDAQ:JBLU), Brunswick Corporation (NYSE:BC), Google Inc (NASDAQ:GOOG) , Riverbed Technology, Inc. (NASDAQ:RVBD), Global Ship Lease, Inc. (NYSE:GSL)
Tech News

Tech News

Tech Analysis & Market News

Newsletter
Random News
  • About TechNews.org
  • Advertising
  • Contact Us
  • Corporate Governance
  • Feedback
  • Locations
  • Philosophy
  • Privacy
  • Reprints
  • TechNews.org Team
Headlines
  • McLaren Formula 1 F1

    McLaren -Honda F1 Team to boost performance through technologies

    5 days ago2 weeks ago
  • Stock in Action: Google (NASDAQ GOOG) Enters the Wireless Market

    5 days ago2 weeks ago
  • Welcome to the Summer of Bitcoin

    4 days ago2 weeks ago
  • Stock Alert: JetBlue Airways Corporation (NASDAQ:JBLU), Brunswick Corporation (NYSE:BC), Google Inc (NASDAQ:GOOG) , Riverbed Technology, Inc. (NASDAQ:RVBD), Global Ship Lease, Inc. (NYSE:GSL)

    4 days ago2 weeks ago
  • Notable Moves: Oracle Corporation (NYSE:ORCL), Transocean Ltd. (NYSE:RIG), Amedisys Inc. (NASDAQ:AMED), Campus Crest Communities, Inc. (NYSE:CCG), Novadaq Technologies Inc. (NASDAQ:NVDQ)

    4 days ago2 weeks ago
  • Mix Sector Stocks: NanoString Technologies, Inc. (NASDAQ:NSTG), McDonald’s Corp. (NYSE:MCD), Integrated Device Technology, Inc. (NASDAQ:IDTI), HMS Holdings Corp. (NASDAQ:HMSY), DeVry Education (NYSE:DV)

    4 days ago2 weeks ago
  • Home
  • BioTech Business News
  • Page 19

BioTech Business News

Biotech stock market news
  • BioTech
  • Finance

Biotech Stocks : Review of Johnson & Johnson and Sarepta Therapeutics

Richard Atkins7 months ago12 years ago02 mins

In this article, we take a look at two very up and coming stocks in Johnson & Johnson and Sarepta Therapeutics. Keep an eye out for Johnson & Johnson (NYSE JNJ) and Sarepta Therapeutics (NASDAQ SRPT). While at one hand, analysts are optimistic about Johnson & Johnson’s second quarter earnings, Sarepta Therapeutics would be looking…

Read More
  • 1
  • …
  • 17
  • 18
  • 19
Newsmatic - News WordPress Theme 2026. Powered By BlazeThemes.